Lansoprazole for Long-Term Maintenance Therapy of Erosive Esophagitis: Double-Blind Comparison with Ranitidine

被引：0

作者：

David A. Peura

James W. Freston

Marian M. Haber

Thomas O. Kovacs

Barbara Hunt

Stuart Atkinson

机构：

[1] University of Virginia Health System,Department of Pathology

[2] University of Connecticut Health Center,undefined

[3] Drexel University College of Medicine,undefined

[4] VA Greater LA Healthcare System,undefined

[5] CURE Clinic,undefined

[6] Takeda Global Research & Development Center,undefined

[7] Inc.,undefined

来源：

Digestive Diseases and Sciences | 2009年 / 54卷

关键词：

Erosive esophagitis; Gastroesophageal reflux disease; Maintenance therapy; Lansoprazole; Heartburn; Ranitidine;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

In a study evaluating the efficacy and safety of lansoprazole to prevent the relapse of erosive esophagitis (EE), 206 of 241 patients (85%) healed after open-label treatment with lansoprazole 30 mg once daily for 8 weeks and received double-blind maintenance treatment with lansoprazole 15 mg once daily or ranitidine 150 mg twice daily for up to 1 year. At 1 year, 67% of lansoprazole-treated and 13% of ranitidine-treated patients remained healed (P < 0.001). Lansoprazole-treated patients experienced significantly greater symptom relief (P < 0.001), and, if asymptomatic at entry into the maintenance phase, remained asymptomatic for significantly longer than ranitidine-treated patients (P < 0.001). Symptom status correlated with healing (P = 0.001), supporting the symptom-directed management of EE. Both treatments were well tolerated and no unexpected events occurred. Daily therapy with lansoprazole to prevent the relapse of EE is effective, well tolerated, and superior to ranitidine in the maintenance of healing and symptom relief.

引用

共 50 条

[11] Double-blind comparison of lansoprazole 15 mg, lansoprazole 30 mg, and placebo in the maintenance of healed gastric ulcer [J].

Kovacs, TOG ;

Campbell, D ;

Haber, M ;

Rose, P ;

Jennings, DE ;

Richter, J .

DIGESTIVE DISEASES AND SCIENCES, 1998, 43 (04) :779-785

[12] Comparison of Tegoprazan and Lansoprazole in Patients With Erosive Esophagitis up to 4 Weeks: A Multi-Center, Randomized, Double-Blind, Active-Comparator Phase 4 Trial [J].

Shin, Cheol Min ;

Choi, Suck Chei ;

Cho, Jin Woong ;

Kim, Seung Young ;

Lee, Ok Jae ;

Kim, Do Hoon ;

Cho, Yu Kyung ;

Lee, Ju Yup ;

Lee, Sang Kil ;

Shin, Jeong Eun ;

Kim, Gwang Ha ;

Park, Seon-Young ;

Hong, Su Jin ;

Jung, Hye-Kyung ;

Lee, Sang Jin ;

Youn, Young Hoon ;

Jeon, Seong Woo ;

Sung, In Kyung ;

Park, Moo In ;

Lee, Oh Young .

NEUROGASTROENTEROLOGY AND MOTILITY, 2025, 37 (01)

[13] Vonoprazan 10 mg or 20 mg vs. lansoprazole 15 mg as maintenance therapy in Asian patients with healed erosive esophagitis: A randomized controlled trial [J].

Xiao, Yinglian ;

Qian, Jiaming ;

Zhang, Shutian ;

Dai, Ning ;

Chun, Hoon Jai ;

Chiu, Chengtang ;

Chong, Chui Fung ;

Funao, Nobuo ;

Sakurai, Yuuichi ;

Eisner, Jessica D. ;

Xie, Li ;

Chen, Minhu .

CHINESE MEDICAL JOURNAL, 2024, 137 (08) :962-971

[14] Effective maintenance treatment of reflux esophagitis with low-dose lansoprazole - A randomized, double-blind, placebo-controlled trial [J].

Robinson, M ;

Lanza, F ;

Avner, D ;

Haber, M .

ANNALS OF INTERNAL MEDICINE, 1996, 124 (10) :859-+

[15] The efficacy and safety of fexuprazan in treating erosive esophagitis: a phase III, randomized, double-blind, multicenter study [J].

Zhuang, Qianjun ;

Liao, Aijun ;

He, Qingling ;

Liu, Chengxia ;

Zheng, Changqing ;

Li, Xing ;

Liu, Youli ;

Wang, Bangmao ;

Liu, Side ;

Zhang, Yan ;

Lin, Rong ;

Chen, Huixin ;

Deng, Min ;

Tang, Yanping ;

He, Chiyi ;

Dai, Weijie ;

Tang, Haitao ;

Gong, Lei ;

Li, Liangping ;

Xu, Baohong ;

Yang, Changqing ;

Zhou, Bingxi ;

Su, Dongxing ;

Guo, Qinghong ;

Li, Bin ;

Zhou, Yongjian ;

Wang, Xiaoyang ;

Fei, Sujuan ;

Wu, Huili ;

Wei, Sichen ;

Peng, Zhihong ;

Wang, Jianning ;

Li, Yanqing ;

Wang, Hong ;

Deng, Tianwei ;

Ding, Shigang ;

Li, Fangfang ;

Chen, Minhu ;

Xiao, Yinglian .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (04) :658-666

[16] Vonoprazan 10 mg or 20 mg vs. lansoprazole 15 mg as maintenance therapy in Asian patients with healed erosive esophagitis: A randomized controlled trial [J].

Xiao Yinglian1 ;

不详 ;

Qian Jiaming1 ;

不详 ;

Zhang Shutian1 ;

不详 ;

Dai Ning1 ;

不详 ;

Chun Hoon Jai18 ;

不详 ;

Chiu Chengtang25 ;

不详 ;

Chong Chui Fung31 ;

不详 ;

Funao Nobuo34 ;

不详 ;

Sakurai Yuuichi34 ;

不详 ;

Eisner Jessica D.38 ;

不详 .

中华医学杂志英文版, 2024, 137 (08)

[17] Esomeprazole for the Treatment of Erosive Esophagitis in Children: An International, Multicenter, Randomized, Parallel-Group, Double-Blind (for Dose) Study [J].

Tolia, Vasundhara ;

Youssef, Nader N. ;

Gilger, Mark A. ;

Traxler, Barry ;

Illueca, Marta .

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2015, 60 :S24-S30

[18] Esomeprazole for the treatment of erosive esophagitis in children: an international, multicenter, randomized, parallel-group, double-blind (for dose) study [J].

Vasundhara Tolia ;

Nader N Youssef ;

Mark A Gilger ;

Barry Traxler ;

Marta Illueca .

BMC Pediatrics, 10 (1)

[19] Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis [J].

Xiao, Yinglian ;

Zhang, Shutian ;

Dai, Ning ;

Fei, Guijun ;

Goh, Khean-Lee ;

Chun, Hoon Jai ;

Sheu, Bor-Shyang ;

Chong, Chui Fung ;

Funao, Nobuo ;

Zhou, Wen ;

Chen, Minhu .

GUT, 2020, 69 (02) :224-230

[20] Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial [J].

Russo, A ;

Dattilo, M .

ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1997, 29 (04) :312-319

← 1 2 3 4 5 →